The Smad6 and Smad7 genes are members of the Smad family, involved in the t
ransforming growth factor-beta (TGF-beta) signaling pathway. Mutations in T
GF-beta receptors and their cytoplasmic elements of transduction signals co
mmonly accompany various cancers. Using PCR-SSCP analysis we searched fur t
he presence of Smad6 and Smad7 gene mutations in 30 human ovarian cancers a
nd 4 ovarian cancer cell lines, and found that 12 cases (35.3%) had a polym
orphism in intron 2 of the Smad6 gene and that 8 cases (23.5%) had a polymo
rphism at codon 208 in the Smad7 gene. Because these polymorphisms were not
accompanied by amino acid substitution, the present results show that the
mutations in the Smad6 and Smad7 genes are unlikely to be involved in human
ovarian cancers.